Elanco Q3 net income swings to $18 million
ELAN•Elanco Animal Health swung to third-quarter 2026 net income of $18 million as revenue rose 11% year over year to $1.27 billion. Credelio Quattro received a positive European Medicines Agency opinion for EU expansion, with launch expected in the first quarter of 2027.
1. Quarterly results
Elanco Animal Health swung to third-quarter 2026 net income of $18 million, while revenue rose 11% year over year to $1.27 billion.
2. EU product expansion
Credelio Quattro received a positive European Medicines Agency opinion for expansion in the EU, with launch expected in the first quarter of 2027.
